iPSCs-BBB研究所

iPSCs-BBB研究所

Open Menu

Joint research

Collaborations

◾️Theodor Kocher Institute, University of Bern, Switzerland
Prof. Britta Engelhard

◾️Department of Physiology, Keio University School of Medicine
Dr. Satoru Morimoto, Prof. Hideyuki Okano
http://www.okano-lab.com

◾️Department of Neurology, Brain Research Institute, Niigata University
Dr. Shoichiro Ando, Prof. Osamu Onodera
https://www.bri.niigata-u.ac.jp/en/index.html

◾️Faculty of Pharmaceutical Sciences, Tokushima University
Dr. Mai Inagaki, Prof. Masanori Tachikawa
創薬理論化学 – 徳島大学薬学部・大学院 (tokushima-u.ac.jp)
最先端研究探訪(とくtalk177号 2019年10月号より) – 国立大学法人 徳島大学 (tokushima-u.ac.jp)
https://www.hiroshima-u.ac.jp/hiraku-g/hgr/inagaki

◾️CHUV, University of Lausanne, Swizerland
Prof. Renaud DuPaquier

◾️MIYAGI CHILDREN’S HOSPITAL
Dr. Kazuhiro Haginoya

◾️Department of Pediatrics, Showa University
Prof Mitsuhiro Kato

◾️Division of Neurology, Tohoku Medical and Pharmaceutical University
Dr. Juichi Fujimori, Prof. Ichiro Nakashima

◾️Department of Neurology, National Hospital Organization Hokkaido Medical Center
Dr. Yusei Miyazaki, Dr. Masaaki Niino

◾️Department of Veterinary Medicine, Yamaguchi University
Dr. Ai Takano

◾️Biological Research Centre, Hungary
Prof. Maria A Deli

◾️Institute of Physiological Chemistry and Pathobiochemistry, University of Muenster
Prof. Lydia Sorokin

◾️Pharmacology & Therapeutics, University of Liverpool
Dr David Dickens

◾️Centro Nacional de Investigaciones Oncológicas (CNIO), Spain
Dr Manuel Valiente

◾️Department of Pathology Neuroscience, Brain Research Institute, Niigata University
Dr Rie Saito

◾️National Cerebral and Cardiovascular Center
Dr Satoshi Saito

We are looking for joint research companies and researchers

Our research laboratory enthusiastically welcomes collaborative research endeavors. Focusing on neurologic disorders and the blood-brain barrier (BBB), we are engaged in pioneering research utilizing unique advanced technologies to create patient-derived BBB models. Researchers interested in studying the BBB in rare diseases, academia and industry professionals intrigued by pathophysiological elucidation and drug discovery using patient-derived BBB models – we invite you to reach out to us without hesitation. Let’s contribute to the future of healthcare together through collaboration. For detailed information on various conditions and other inquiries, please feel free to contact us.